EUDA
EUDA Health Holdings LimitedNASDAQREAL ESTATEREAL ESTATE SERVICES
Key Statistics
Market Cap
$43.30M
P/E Ratio
—
EPS
$-1.48
Beta
0.56
52W High
$86.00
52W Low
$5.26
50-Day MA
$11.02
200-Day MA
$33.21
Dividend Yield
—
Profit Margin
-40.70%
Forward P/E
10.92
PEG Ratio
—
About EUDA Health Holdings Limited
EUDA Health Holdings Limited is a biopharmaceutical innovator dedicated to the discovery, development, and commercialization of transformative therapies for rare diseases and unmet medical needs. The company utilizes cutting-edge technologies and maintains a strong clinical pipeline, emphasizing supportive care and immune modulation. With a deep commitment to research and development, EUDA is strategically positioned to drive healthcare advancements, improve patient outcomes, and broaden access to vital medical treatments.
Fundamentals
| Revenue (TTM) | $6.82M |
| Gross Profit (TTM) | $2.99M |
| EBITDA | $-2.24M |
| Operating Margin | -34.80% |
| Return on Equity | 0.00% |
| Return on Assets | -89.30% |
| Revenue/Share (TTM) | $3.65 |
| Book Value | $-2.25 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 6.35 |
| EV/Revenue | 6.69 |
| EV/EBITDA | -25.90 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 78.90% |
| Shares Outstanding | $2.49M |
| Float | $1.19M |
| % Insiders | 37.59% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
111.83%
HV 20-Day
137.86%
HV 30-Day
147.51%
HV 60-Day
160.76%
HV Rank
—
Volatility is currently contracting
More REAL ESTATE Stocks
Data last updated: 5/25/2026